Gentian Diagnostics AS (OSL:GENT) 3-Year Book Growth Rate : -9.00% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS 3-Year Book Growth Rate?

Gentian Diagnostics AS's Book Value per Share for the quarter that ended in Sep. 2024 was kr10.47.

During the past 12 months, Gentian Diagnostics AS's average Book Value per Share Growth Rate was 3.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was -9.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was -9.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 35.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Gentian Diagnostics AS was 315.10% per year. The lowest was -10.80% per year. And the median was 2.85% per year.

Competitive Comparison of Gentian Diagnostics AS's 3-Year Book Growth Rate

For the Medical Devices subindustry, Gentian Diagnostics AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gentian Diagnostics AS's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's 3-Year Book Growth Rate falls into.

Gentian Diagnostics AS 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Gentian Diagnostics AS (OSL:GENT) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Gentian Diagnostics AS 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.